No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025
BofA Securities Maintains Cronos Group(CRON.US) With Sell Rating, Cuts Target Price to $1.65
Cronos Group Price Target Lowered to $1.65 From $2 at BofA
Express News | 'Marijuana Rescheduling Isn't On The White House's New List Of Top Drug Policy Priorities Under The Trump Administration' - Marijuana Moment
Canadian Stock Movers for Tuesday | Torex Gold Resources Inc Was the Top Gainer; Medical Devices & Instruments Led Gains
